Login to Your Account

Luye aims big; plans Hong Kong IPO to raise up to $800M

By Cornelia Zou
Staff Writer

Wednesday, July 2, 2014

HONG KONG – A Chinese maker of novel oncology, cardiovascular and metabolic drugs is floating shares in Hong Kong next month and has developed a plan to set itself apart from the pack.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription